Could a simple chatbot ease the burden of cancer treatment?
NCT ID NCT07310589
Summary
This study is testing a special chatbot on the LINE app to see if it helps people with advanced lung cancer better manage the side effects of their oral medication. About 178 participants will be randomly assigned to receive either their usual care or usual care plus access to this interactive tool, which provides visual guides and tips for self-care. The main goal is to see if the chatbot improves patients' confidence and ability to handle symptoms and improves their quality of life during treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.